BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

616 related articles for article (PubMed ID: 12669022)

  • 1. PI3K in lymphocyte development, differentiation and activation.
    Okkenhaug K; Vanhaesebroeck B
    Nat Rev Immunol; 2003 Apr; 3(4):317-30. PubMed ID: 12669022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired B and T cell antigen receptor signaling in p110delta PI 3-kinase mutant mice.
    Okkenhaug K; Bilancio A; Farjot G; Priddle H; Sancho S; Peskett E; Pearce W; Meek SE; Salpekar A; Waterfield MD; Smith AJ; Vanhaesebroeck B
    Science; 2002 Aug; 297(5583):1031-4. PubMed ID: 12130661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of PI3K in the generation and survival of B cells.
    Werner M; Hobeika E; Jumaa H
    Immunol Rev; 2010 Sep; 237(1):55-71. PubMed ID: 20727029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphoinositide 3-kinase and its targets in B-cell and T-cell signaling.
    Fruman DA
    Curr Opin Immunol; 2004 Jun; 16(3):314-20. PubMed ID: 15134780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuation of phosphoinositide 3-kinase δ signaling restrains autoimmune disease.
    Maxwell MJ; Tsantikos E; Kong AM; Vanhaesebroeck B; Tarlinton DM; Hibbs ML
    J Autoimmun; 2012 Jun; 38(4):381-91. PubMed ID: 22537464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ras initiates phosphatidyl-inositol-3-kinase (PI3K)/PKB mediated signalling pathways in untransformed human peripheral blood T lymphocytes.
    Samstag Y; Nebl G
    Adv Enzyme Regul; 2005; 45():52-62. PubMed ID: 16083947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired B cell development and proliferation in absence of phosphoinositide 3-kinase p85alpha.
    Fruman DA; Snapper SB; Yballe CM; Davidson L; Yu JY; Alt FW; Cantley LC
    Science; 1999 Jan; 283(5400):393-7. PubMed ID: 9888855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of mitogen-activated protein kinases in Thy-1-induced T-lymphocyte activation.
    Conrad DM; Furlong SJ; Doucette CD; Boudreau RT; Hoskin DW
    Cell Signal; 2009 Aug; 21(8):1298-307. PubMed ID: 19324083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tyrosine kinases and their substrates in B lymphocytes.
    Kurosaki T; Hikida M
    Immunol Rev; 2009 Mar; 228(1):132-48. PubMed ID: 19290925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tec family kinases in T lymphocyte development and function.
    Berg LJ; Finkelstein LD; Lucas JA; Schwartzberg PL
    Annu Rev Immunol; 2005; 23():549-600. PubMed ID: 15771581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphoinositide 3-kinase: diverse roles in immune cell activation.
    Deane JA; Fruman DA
    Annu Rev Immunol; 2004; 22():563-98. PubMed ID: 15032589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced phosphoinositide 3-kinase δ activity is a frequent event in systemic lupus erythematosus that confers resistance to activation-induced T cell death.
    Suárez-Fueyo A; Barber DF; Martínez-Ara J; Zea-Mendoza AC; Carrera AC
    J Immunol; 2011 Sep; 187(5):2376-85. PubMed ID: 21810603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphoinositide 3-kinase in T cell activation and survival.
    Okkenhaug K; Bilancio A; Emery JL; Vanhaesebroeck B
    Biochem Soc Trans; 2004 Apr; 32(Pt 2):332-5. PubMed ID: 15046602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B cell receptor signaling: picky about PI3Ks.
    Limon JJ; Fruman DA
    Sci Signal; 2010 Aug; 3(134):pe25. PubMed ID: 20699473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting lymphocyte co-stimulation: from bench to bedside.
    Felix NJ; Suri A; Salter-Cid L; Nadler SG; Gujrathi S; Corbo M; Aranda R
    Autoimmunity; 2010 Nov; 43(7):514-25. PubMed ID: 20429850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered splenic B cell subset development in mice lacking phosphoinositide 3-kinase p85alpha.
    Donahue AC; Hess KL; Ng KL; Fruman DA
    Int Immunol; 2004 Dec; 16(12):1789-98. PubMed ID: 15520044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The function of E- and Id proteins in lymphocyte development.
    Engel I; Murre C
    Nat Rev Immunol; 2001 Dec; 1(3):193-9. PubMed ID: 11905828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Class IA phosphoinositide 3-kinase modulates basal lymphocyte motility in the lymph node.
    Matheu MP; Deane JA; Parker I; Fruman DA; Cahalan MD
    J Immunol; 2007 Aug; 179(4):2261-9. PubMed ID: 17675487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PI3K signaling controls cell fate at many points in B lymphocyte development and activation.
    Donahue AC; Fruman DA
    Semin Cell Dev Biol; 2004 Apr; 15(2):183-97. PubMed ID: 15209378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphoinositide 3-kinases in T lymphocyte activation.
    Ward SG; Cantrell DA
    Curr Opin Immunol; 2001 Jun; 13(3):332-8. PubMed ID: 11406365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.